News Conference News ACC 2026 SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too Caitlin E. Cox March 30, 2026
News Conference News ACC 2026 SPIRIT-HF: Spironolactone’s Benefit Still Uncertain in HF With Preserved, Mildly Reduced EF Todd Neale March 29, 2026
News Daily News Ultraprocessed Food Again Linked to Higher CVD Risk: MESA Michael O'Riordan March 17, 2026
News Conference News THT 2026 AI for Heart Failure Care Is Evolving Rapidly, THT 2026 Makes Clear Todd Neale March 10, 2026
News Conference News THT 2026 Should Moderate FMR Be Treated With M-TEER? Experts Duke It Out Todd Neale March 06, 2026
News Conference News THT 2026 Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data Todd Neale March 05, 2026
News Conference News THT 2026 NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER Todd Neale March 04, 2026
Presentation THT Abstracts 2026 SGLT2 Inhibitor Outcomes In Adult Congenital Heart Disease: A Retrospective Cohort Study Presenter: Shaival Sharma March 02, 2026
Presentation THT Abstracts 2026 Real-World Association of SGLT2 Inhibitors With Survival and Arrhythmic Risk in Advanced Cardio-Renal Disease Presenter: Mazen Ahmed March 02, 2026
News Features Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts Michael O'Riordan February 24, 2026
News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Daily News Nearly 150 Million US Adults Eligible for CKM Syndrome Meds Caitlin E. Cox February 02, 2026
News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025